You just clicked a link to go to another website. If you continue, you will leave this site and go to a site run by someone else.
Medtronic does not review or control the content on the other website, and we are not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.
It is possible that some of the products on the other site are not approved in the United Kingdom.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations, except those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011, article 34.
Click “OK” to confirm you are a Healthcare Professional.
Juan Carlos was diagnosed with Barrett’s oesophagus during a routine endoscopy. A follow-up biopsy brought worse news: he also had high-grade dysplasia, meaning that part of his oesophagus was becoming cancerous.
Barrett’s oesophagus is a condition in which damage to the lining of the oesophagus results in abnormal cell growth, which can lead to oesophageal cancer.
According to Dr. José Miguel Esteban, Chief of the Endoscopy Department at Hospital Clinico Scan Carlos and Hospital Ruber Internacional in Madrid, Spain (and Juan Carlos’ physician) many people in our society suffer from Barrett’s without knowing it. They may experience GORD symptoms for 10 to 20 years, but they don’t take it seriously enough to seek treatment. When they eventually get a routine endoscopy, like Juan Carlos did, they discover that they have Barrett’s.
“The problem,” said Dr. Esteban, “is that when people finally come in for a biopsy, we find high-grade dysplasia, and it’s just one step before cancer.”
The problem is that when people finally come in for a biopsy, we find high-grade dysplasia, and it’s just one step before cancer.
Dr. Esteban
The first doctor Juan Carlos saw told him that the only possible solution for his Barrett’s was surgery — but that there was a 20% chance that the surgery would kill him. Juan Carlos didn’t like those odds, so he went online to do some research of his own. He connected with other Barrett’s patients and learned about a treatment called radiofrequency ablation (RFA).
“I realised radiofrequency ablation could be the salvation for my disease,” said Juan Carlos. After some more digging, he discovered that there was a hospital in Madrid, just two hours from his home, that practiced RFA. He reached out to Dr. Esteban for treatment.
RFA is an endoscopy treatment that uses heat to remove tissue affected by Barrett’s oesophagus. The treatment takes just 20–30 minutes, and patients are sent home 3 or 4 hours later with diet recommendations and medication. After 10–12 weeks, they’ll come back for a second treatment. On average, it takes two treatments to eradicate all the tissue damaged by Barrett’s.
“Paradoxically, after a grim initial diagnosis, my prospects improved,” Juan Carlos said. “Dr. Esteban told me, ‘Relax, there’s a minimally invasive treatment for Barrett’s. You can stop worrying now, we’ll treat you.’”
Information and resources on this site should not be used as a substitute for medical advice from your doctor. Always discuss diagnosis and treatment information including risks with your doctor. Keep in mind that all treatment and outcome results are specific to the individual patient. Results may vary.